6411 - 6420 of 9140 Results
Title
Year
- Atrophy and structural covariance of the cholinergic basal forebrain in primary progressive aphasia2016OPENTitle: Atrophy and structural covariance of the cholinergic basal forebrain in primary progressive aphasiaJournal Name: CortexPublisher: Elsevier BVVol: 83Issue #:Start Page: 124End Page: 135Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cortex.2016.07.004Best OA location URL: https://doi.org/10.1016/j.cortex.2016.07.004Citation Count: 23
- Anti-dyskinetic effect of anpirtoline in animal models of L-DOPA-induced dyskinesia2013RESTRICTEDTitle: Anti-dyskinetic effect of anpirtoline in animal models of L-DOPA-induced dyskinesiaJournal Name: Neuroscience ResearchPublisher: Elsevier BVVol: 77Issue #: 4Start Page: 242End Page: 246Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.neures.2013.10.002Citation Count: 47
-
OPENTitle: Use of receptor and nonreceptor tyrosine kinase inhibitors and Parkinson disease riskJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 23Issue #: 5Start Page: e01040End Page: e01040Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neurot.2026.e01040Best OA location URL: https://doi.org/10.1016/j.neurot.2026.e01040Citation Count: 0
-
OPENTitle: A novel stable transgenic zebrafish line expressing mCherry-tagged human alpha-synuclein in the nervous system and exhibiting all the key features of Lewy body disorders at larval stageJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 213Issue #:Start Page: 107018End Page: 107018Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2025.107018Best OA location URL: https://doi.org/10.1016/j.nbd.2025.107018Citation Count: 2
-
OPENTitle: Contrast Acuity With Different Colors in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 6Issue #: 8Start Page: 672End Page: 677Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12821Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12821Citation Count: 7
-
OPENTitle: PINK 1 autophosphorylation is required for ubiquitin recognitionJournal Name: The EMBO ReportsPublisher: Springer Science and Business Media LLCVol: 19Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.15252/embr.201744981Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.15252/embr.201744981Citation Count: 117
-
OPENTitle: Coordinated reset vibrotactile stimulation shows prolonged improvement in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 1Start Page: 179End Page: 180Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27223Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27223Citation Count: 40
- TNF-α knockout and minocycline treatment attenuates blood–brain barrier leakage in MPTP-treated mice2007OPENTitle: TNF-α knockout and minocycline treatment attenuates blood–brain barrier leakage in MPTP-treated miceJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 26Issue #: 1Start Page: 36End Page: 46Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2006.11.012Best OA location URL: https://doaj.org/article/e30977e5fbe84409a2cee00917b4ca29Citation Count: 182
- An mGlu4‐Positive Allosteric Modulator Alleviates Parkinsonism in Primates2018RESTRICTEDTitle: An mGlu4‐Positive Allosteric Modulator Alleviates Parkinsonism in PrimatesJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 10Start Page: 1619End Page: 1631Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27462Citation Count: 58
- Activation of mGlu2/3 receptors, a novel therapeutic approach to alleviate dyskinesia and psychosis in experimental parkinsonism2019RESTRICTEDTitle: Activation of mGlu2/3 receptors, a novel therapeutic approach to alleviate dyskinesia and psychosis in experimental parkinsonismJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 158Issue #:Start Page: 107725End Page: 107725Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2019.107725Citation Count: 40